Filed by Soaring Eagle Acquisition Corp. pursuant to
Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12
under the Securities Exchange Act of 1934
Subject Company: Ginkgo Bioworks, Inc.
Commission File No.: 333-256121
Ginkgo Bioworks Announces Participation in Upcoming Conferences
BOSTON, MA July 29, 2021 Ginkgo Bioworks, Inc. (Ginkgo), which recently announced a business combination with Soaring Eagle
Acquisition Corp. (Nasdaq:SRNG), is scheduled to participate in the following upcoming conferences:
|
|
|
Management will participate in
one-on-one meetings and a fireside chat at the Jefferies Virtual Industrials Conference on Wednesday, August 4, 2021, at 10:30 a.m. Eastern Time.
|
|
|
|
Management will participate in
one-on-one meetings and give a presentation at the UBS Genomics 2.0 and Medtech Innovations Summit in Laguna Beach, California on Wednesday,
August 11, 2021, at 10:00 a.m. Pacific Time (1:00 p.m. Eastern Time).
|
Live webcasts, as well as replays, of the fireside chat and
presentation will be available on the companys investor relations website at https://www.ginkgobioworks.com/investors/.
About Ginkgo
Bioworks
Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The companys platform is
enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo is also actively supporting a number of COVID-19 response efforts,
including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery. In May 2021, Ginkgo announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), which, if
completed, will result in Ginkgo, through a parent entity, Ginkgo Bioworks Holdings, Inc., becoming a public company. The transaction is expected to close in the third quarter of 2021, subject to regulatory and shareholder approvals, and other
customary closing conditions. For more information, visit www.ginkgobioworks.com.
MEDIA CONTACT:
press@ginkgobioworks.com
INVESTOR
CONTACT:
investors@ginkgobioworks.com
ADDITIONAL LEGAL INFORMATION
Forward-Looking Statements Legend
This document contains
certain forward-looking statements within the meaning of the federal securities laws with respect to the proposed transaction between Ginkgo and Soaring Eagle Acquisition Corp. (SRNG), including statements regarding the
benefits of the transaction, the anticipated timing of the transaction, the services offered by Ginkgo and the markets in which it operates, and Ginkgos projected future results. These forward-looking statements generally are identified by the
words believe, project, expect, anticipate, estimate, intend, strategy,